Published in Front Neurol on March 12, 2015
Exercise, inflammation, and fatigue in cancer survivors. Exerc Immunol Rev (2016) 0.81
Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation. Front Cell Neurosci (2015) 0.79
Disease-Induced Skeletal Muscle Atrophy and Fatigue. Med Sci Sports Exerc (2016) 0.77
Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1β: Investigating a Method for the Study of Fatigue in Laboratory Animals. PLoS One (2015) 0.77
A training approach to improve stepping automaticity while dual-tasking in Parkinson's disease: A prospective pilot study. Medicine (Baltimore) (2017) 0.77
Fatigue Management in Multiple Sclerosis. Curr Treat Options Neurol (2016) 0.75
Basal ganglia correlates of fatigue in young adults. Sci Rep (2016) 0.75
Clinical characteristics of fatigued Parkinson's patients and the response to dopaminergic treatment. Transl Neurodegener (2016) 0.75
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. J Neuroinflammation (2016) 0.75
Fatigue in Multiple Sclerosis: Misconceptions and Future Research Directions. Front Neurol (2016) 0.75
Role of Inflammation in Human Fatigue: Relevance of Multidimensional Assessments and Potential Neuronal Mechanisms. Front Immunol (2017) 0.75
Effect of vitamin D3 on self-perceived fatigue: A double-blind randomized placebo-controlled trial. Medicine (Baltimore) (2016) 0.75
The relationship between outcome prediction and cognitive fatigue: A convergence of paradigms. Cogn Affect Behav Neurosci (2017) 0.75
Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol (2017) 0.75
The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med (1994) 26.24
Predictive reward signal of dopamine neurons. J Neurophysiol (1998) 15.02
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32
Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci (2000) 6.02
The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol (2004) 5.66
Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J Neurosci (2006) 3.87
Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry (2011) 3.78
Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry (2002) 2.97
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology (2005) 2.95
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology (1995) 2.90
Dopamine and the regulation of cognition and attention. Prog Neurobiol (2002) 2.72
Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci (2001) 2.41
Structure and function of dopamine receptors. Neurosci Biobehav Rev (2000) 2.40
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol (2010) 2.28
Influence of reward expectation on behavior-related neuronal activity in primate striatum. J Neurophysiol (1998) 2.11
Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther (2003) 2.10
Fatigue and basal ganglia. J Neurol Sci (2000) 1.82
Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol (2001) 1.65
Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology (1997) 1.55
Dopamine, serotonin and impulsivity. Neuroscience (2012) 1.41
Interferon-beta mechanisms of action in multiple sclerosis. Neurology (2010) 1.40
Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol (2012) 1.35
Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum. J Neurosci (2006) 1.35
The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. J Exp Anal Behav (2012) 1.33
Approved and investigational uses of modafinil : an evidence-based review. Drugs (2008) 1.28
Dopaminergic control of cognitive flexibility in humans and animals. Front Neurosci (2013) 1.28
Central fatigue: the serotonin hypothesis and beyond. Sports Med (2006) 1.26
Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol (2000) 1.25
Methylphenidate for fatigue in ambulatory men with prostate cancer. Cancer (2010) 1.23
Dopamine modulates neural networks involved in effort-based decision-making. Neurosci Biobehav Rev (2008) 1.19
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain (2010) 1.17
Accumbens dopamine and the regulation of effort in food-seeking behavior: modulation of work output by different ratio or force requirements. Behav Brain Res (2004) 1.17
Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation. Cogn Affect Behav Neurosci (2005) 1.17
I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res (2010) 1.16
Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction. J Neurol Sci (2011) 1.13
Reduction of serotonin transporters of patients with chronic fatigue syndrome. Neuroreport (2004) 1.11
Jumping the gun: is effective preparation contingent upon anticipatory activation in task-relevant neural circuitry? Cereb Cortex (2005) 1.09
Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev (2007) 1.09
Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction. JAMA Psychiatry (2013) 1.08
The neuroimmune basis of fatigue. Trends Neurosci (2013) 1.05
Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease. J Immunol (2013) 1.05
A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med (2001) 1.03
The dopaminergic system in autoimmune diseases. Front Immunol (2014) 1.02
Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study. Clin Neurol Neurosurg (2013) 1.02
Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era. AIDS (2010) 1.01
The basal ganglia: a substrate for fatigue in multiple sclerosis. Neuroradiology (2007) 0.99
Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Mov Disord (2007) 0.98
Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? J Neuroimmune Pharmacol (2012) 0.98
Frontal networks play a role in fatigue perception in multiple sclerosis. Behav Neurosci (2010) 0.96
Management of fatigue in patients with multiple sclerosis. Drugs (2004) 0.96
Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis. PLoS One (2013) 0.94
Neurobiological studies of fatigue. Prog Neurobiol (2012) 0.94
Acute basal ganglia infarcts in poststroke fatigue: an MRI study. J Neurol (2009) 0.93
Functional significance of central D1 receptors in cognition: beyond working memory. J Cereb Blood Flow Metab (2012) 0.93
Neural correlates of cognitive fatigue: cortico-striatal circuitry and effort-reward imbalance. J Int Neuropsychol Soc (2013) 0.93
Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging. PLoS One (2013) 0.91
The dopamine agonist bromocriptine differentially affects fronto-striatal functional connectivity during working memory. Front Hum Neurosci (2011) 0.91
Fatigue in Parkinson's disease. Expert Opin Pharmacother (2011) 0.90
Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon β. Int J Neurosci (2010) 0.90
Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue. PLoS One (2014) 0.88
Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process. J Neurol Sci (2008) 0.88
Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis. Psychoneuroendocrinology (1994) 0.88
Role of serotonin in central dopamine dysfunction. CNS Neurosci Ther (2010) 0.88
The effects of methylphenidate on whole brain intrinsic functional connectivity. Hum Brain Mapp (2014) 0.87
Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task. Psychopharmacology (Berl) (2013) 0.87
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta. J Interferon Cytokine Res (2005) 0.86
Spatially distributed effects of mental exhaustion on resting-state FMRI networks. PLoS One (2014) 0.86
Association between white matter fiber structure and reward-related reactivity of the ventral striatum. Hum Brain Mapp (2013) 0.85
Serotonin innervation of basal ganglia in monkeys and humans. J Chem Neuroanat (2011) 0.85
Central fatigue and neurotransmitters, can thermoregulation be manipulated? Scand J Med Sci Sports (2010) 0.85
Poststroke fatigue is associated with caudate infarcts. J Neurol Sci (2012) 0.84
Thalamo-striato-cortical determinants to fatigue in multiple sclerosis. Brain Behav (2013) 0.84
Factors associated with response to methylphenidate in advanced cancer patients. Oncologist (2011) 0.84
Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage (2012) 0.83
Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med (2006) 0.83
Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis. J Neuroimmunol (2005) 0.83
Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis. Exp Neurol (2008) 0.83
Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue. Mult Scler (2014) 0.82
Twenty-five years of research on the behavioural malaise associated with influenza and the common cold. Psychoneuroendocrinology (2012) 0.81
Tryptophan depletion in chronic fatigue syndrome, a pilot cross-over study. BMC Res Notes (2014) 0.81
Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy. Neuroimmunomodulation (2012) 0.81
Ventromedial prefrontal cortex modulates fatigue after penetrating traumatic brain injury. Neurology (2010) 0.81
An approach for identifying brainstem dopaminergic pathways using resting state functional MRI. PLoS One (2014) 0.80
What is post TBI fatigue? NeuroRehabilitation (2013) 0.80
Methylphenidate: established and expanding roles in symptom management. Am J Hosp Palliat Care (2011) 0.78
Evaluation of dosage, safety and effects of methylphenidate on post-traumatic brain injury symptoms with a focus on mental fatigue and pain. Brain Inj (2013) 0.78
Reductions in frontocortical cytokine levels are associated with long-lasting alterations in reward valuation after methamphetamine. Neuropsychopharmacology (2015) 0.78
Detecting cognitive fatigue in multiple sclerosis: method matters. J Neurol Sci (2012) 0.77
Altered serotonin transporter availability in patients with multiple sclerosis. Eur J Nucl Med Mol Imaging (2014) 0.77
Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology. Exp Brain Res (2013) 0.77
Serotonergic action on dorsal striatal function. Parkinsonism Relat Disord (2012) 0.77
You can't always get what you want: the influence of unexpected task constraint on voluntary task switching. Q J Exp Psychol (Hove) (2014) 0.76
Are there control processes, and (if so) can they be studied? Psychol Res (2011) 0.75